Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2021-10-22 Regulatory Filings
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Contract awards
Regulatory Filings Classification · 1% confidence The document is identified by the RNS Number header and contains a brief announcement dated October 22, 2021, regarding 'Contract awards' received by Physiomics plc from an existing client, Merck KGaA. The text is short (3219 characters) and describes a specific business event (new contract win) rather than a comprehensive financial report (like 10-K or IR) or a formal regulatory filing requiring detailed disclosure. The footer explicitly states, 'Reach is a non-regulatory news service,' and the announcement is distributed via 'Reach, the non-regulatory press release distribution service of RNS.' Since this is a specific, non-core regulatory announcement (not related to dividends, management changes, or major shareholdings) and is explicitly labeled as non-regulatory news distributed via the RNS platform, the most appropriate classification is the general fallback for miscellaneous regulatory/news announcements, which is RNS.
2021-10-22 English
Results Presentation and DoseMeRx Update
Report Publication Announcement Classification · 1% confidence The document is identified by the RNS Number header and the closing statement referencing RNS, the news service of the London Stock Exchange. The content explicitly states that the company 'today made a presentation regarding its final results for the year ended 30 June 2021, using the Investor Meet Company platform.' It further mentions that the slide deck used in the presentation will be posted on the website. This structure—announcing a presentation/results briefing and stating where the materials (slide deck) will be posted—fits the definition of a Report Publication Announcement (RPA). It is not the full Annual Report (10-K) or the Investor Presentation (IP) itself, but the announcement about the presentation of those results.
2021-09-30 English
Final Results
Earnings Release Classification · 1% confidence The document explicitly states 'Final Results for the year ended 30 June 2021' and provides detailed 'Financial Highlights' (income, operating loss, loss after taxation, shareholders' funds, cash) and an 'Operational highlights' section. This content structure is characteristic of a company's primary annual financial disclosure. Although it also mentions the 'Annual General Meeting' date, the core of the document is the comprehensive review of the full fiscal year's performance. In the context of the provided definitions, this is the Annual Report (10-K), even if the filing might technically be an RNS announcement containing the results, the content itself is the Annual Report data. Given the length (over 100k characters) and depth of financial review, it is classified as the report itself, not just a publication announcement (RPA). FY 2021
2021-09-30 English
PARNTER study recruits first patient
Legal Proceedings Report Classification · 1% confidence The document begins with 'RNS Number : 0507M' and is dated 16 September 2021. It announces a specific operational update: 'Physiomics plc... is pleased to announce its PARTNER study has recruited its first patient.' This is a timely, non-periodic announcement regarding company progress, not a comprehensive financial report (like 10-K or IR) or a formal regulatory filing like a director's dealing or capital change. The presence of the RNS header and the nature of the announcement (a specific operational milestone) strongly suggest it is a general regulatory announcement distributed via the London Stock Exchange's news service. Since it doesn't fit the specific categories like ER, DIV, or DIRS, the most appropriate fallback is Regulatory Filings (RNS). The document length is moderate (5572 chars), but its content is purely an announcement of an event, not the attachment or summary of a major report.
2021-09-16 English
Notice of Results and Investor Presentation
Report Publication Announcement Classification · 1% confidence The document is a short announcement (3219 characters) released via RNS (RNS Number: 7728L) on September 15, 2021. The title is "Notice of Results and Investor Presentation." The text explicitly states that the company "will publish its results for the full year ending 30 June 2021 on Thursday, 30 September" and announces a live presentation relating to those results. Since the document is an announcement about the future publication of results and an associated presentation, rather than the results document itself (like an ER or 10-K) or the presentation slides (IP), it fits the definition of a Report Publication Announcement (RPA). This aligns with Rule 2 (The 'Menu vs Meal' Rule) as it announces the upcoming release of reports/events.
2021-09-15 English
Physiomics hires Head of Business Development
Board/Management Information Classification · 1% confidence The document is very short (3596 characters) and announces a specific, non-financial event: the hiring of a new Head of Business Development. It is distributed via RNS (indicated by 'RNS Number' and references to RNS/LSE) but explicitly states it is a 'Reach' announcement, which is a 'non-regulatory press release distribution service' and confirms the information is of a 'non-regulatory nature'. Since the content is an announcement of personnel change (Board/Management Information), the most specific code is MANG. However, because it is explicitly flagged as a non-regulatory press release distributed via a service that mimics RNS distribution, and it doesn't fit the strict definitions of DIRS, DIV, or CAP, the general Regulatory Filings (RNS) category is often used for non-core, non-mandatory announcements distributed through this channel, especially when the content is personnel news which isn't explicitly covered by a dedicated non-regulatory code. Given the options, MANG (Board/Management Information) is the most accurate description of the *content* (hiring senior staff). Since MANG is a specific category, it takes precedence over the general RNS fallback, even if the distribution method is non-regulatory.
2021-08-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.